Access cutting-edge central nervous system lymphoma treatment through this clinical trial at a research site in Commack. Study-provided care at no cost to qualified participants.
Access central nervous system lymphoma specialists in Commack at no cost
This study follows strict safety protocols and ethical guidelines
All study-related central nervous system lymphoma treatment provided free
The purpose of this study is to test any good or bad effects of the study drug called of ibrutinib (also known as Imbruvica™). At this stage of this trial, the study is investigating whether Ibrutinib can be incorporated into the established first-line chemotherapy regimen rituximab, methotrexate, vincristine, and procarbazine (R-VMP) in order to further refine the first-line induction therapy for PCNSL, as observed by a superior CRR (complete response rate) (ARM D RECRUITING ONLY)
Sponsor: Memorial Sloan Kettering Cancer Center
Check if you qualify for this central nervous system lymphoma clinical trial in Commack, NY
If you're searching for central nervous system lymphoma treatment options in Commack, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Commack research site is actively enrolling participants for this clinical trial. You'll receive care from experienced central nervous system lymphoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.